PUXEDDU, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 14.324
AS - Asia 3.001
EU - Europa 2.146
SA - Sud America 565
AF - Africa 139
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.195
Nazione #
US - Stati Uniti d'America 11.829
CA - Canada 2.449
SG - Singapore 1.077
CN - Cina 822
IT - Italia 644
HK - Hong Kong 548
SE - Svezia 498
BR - Brasile 464
DE - Germania 208
BG - Bulgaria 199
VN - Vietnam 186
GB - Regno Unito 149
RU - Federazione Russa 124
IN - India 83
TR - Turchia 76
AT - Austria 55
CI - Costa d'Avorio 50
FR - Francia 50
FI - Finlandia 47
BE - Belgio 40
AR - Argentina 34
UA - Ucraina 31
BD - Bangladesh 27
IQ - Iraq 26
JP - Giappone 24
MX - Messico 24
KR - Corea 23
NG - Nigeria 23
PL - Polonia 21
SN - Senegal 17
NL - Olanda 16
ZA - Sudafrica 16
ID - Indonesia 14
AU - Australia 13
CO - Colombia 13
PK - Pakistan 13
VE - Venezuela 13
CZ - Repubblica Ceca 12
ES - Italia 12
UZ - Uzbekistan 12
EC - Ecuador 11
GR - Grecia 11
SA - Arabia Saudita 11
UY - Uruguay 9
PH - Filippine 8
CL - Cile 7
EG - Egitto 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
IE - Irlanda 6
CH - Svizzera 5
CR - Costa Rica 5
DZ - Algeria 5
IL - Israele 5
JM - Giamaica 5
LT - Lituania 5
MA - Marocco 5
TN - Tunisia 5
AZ - Azerbaigian 4
BO - Bolivia 4
KE - Kenya 4
NP - Nepal 4
OM - Oman 4
TW - Taiwan 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
IR - Iran 3
LB - Libano 3
MD - Moldavia 3
PT - Portogallo 3
TH - Thailandia 3
HN - Honduras 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BF - Burkina Faso 1
BJ - Benin 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
PR - Porto Rico 1
RO - Romania 1
SR - Suriname 1
Totale 20.192
Città #
Dallas 6.114
Montreal 2.325
Woodbridge 645
Ashburn 637
Singapore 579
Fairfield 543
Hong Kong 538
Houston 494
Santa Clara 476
Chandler 297
Ann Arbor 286
Seattle 254
Shanghai 218
Beijing 200
Sofia 198
Wilmington 187
New York 185
Cambridge 180
Pisa 138
Boardman 120
Milan 116
Los Angeles 96
Princeton 87
Lawrence 84
Ottawa 84
Medford 81
Des Moines 73
Serra 61
Munich 60
London 57
Abidjan 50
Nanjing 49
Vienna 47
São Paulo 45
Florence 41
Redondo Beach 40
Brussels 39
Dong Ket 38
Buffalo 36
San Diego 36
Hefei 35
Dearborn 33
Istanbul 29
Bremen 28
Chicago 27
Frankfurt am Main 27
Ho Chi Minh City 26
Rome 25
Hanoi 24
Izmir 24
Nanchang 24
North Bergen 24
Lagos 23
Pune 20
Rio de Janeiro 20
Livorno 19
Seoul 18
Dakar 17
San Jose 17
Tokyo 17
Warsaw 17
Council Bluffs 16
Redwood City 16
Toronto 16
Turku 16
Nuremberg 15
Denver 14
Jacksonville 14
Shenyang 14
Changsha 13
Fuzhou 13
Kunming 13
Belo Horizonte 12
Tashkent 12
Paris 11
Boston 10
Dhaka 10
Poplar 10
Quanzhou 10
Düsseldorf 9
Guangzhou 9
Hyderabad 9
Mexico City 9
Orem 9
Stockholm 9
Baghdad 8
Columbus 8
Falls Church 8
Montevideo 8
Norwalk 8
Ogden 8
San Francisco 8
Auburn Hills 7
Brooklyn 7
Chennai 7
Da Nang 7
Johannesburg 7
Lucca 7
Terni 7
The Dalles 7
Totale 16.729
Nome #
08.20 Acpa fingerprinting in established rheumatoid arthritis 8.476
Angiogenesis in spondyloarthritis: target for new diagnostic approaches 210
Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant. 182
Distinct profile of inflammatory and remodelling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction 180
Effectiveness of enzymatic hydrolysis for reducing the allergenic potential of legume by-products 178
Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies. 165
ANTI-CITRULLINATED ALPHA ENOLASE ANTIBODIES, INTERSTITIAL LUNG DISEASE AND BONE EROSION IN RHEUMATOID ARTHRITIS 162
Potential biomarkers in patients with systemic sclerosis 159
CCL5/RANTES, sVCAM-1, and sICAM-1 in chronic spontaneous urticaria. 159
Defective epithelial barrier function in asthma 158
Microvascular Endothelial Dysfunction in Patients with Obesity 157
Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases 154
Eosinophil major basic protein: first identified natural heparanase-inhibiting protein 154
Endostatin and Thrombospondin-1 levels are increased in the sera of patients with chronic spontaneous urticaria. 153
Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications. 153
Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria. 149
Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in mixed cryoglobulinemia. 144
Renal Involvement in IgG4-Related Disease: From Sunlight to Twilight 144
Mediators of angiogenesis and fibrosis in IgG4-related disease. 143
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms 142
IL-1 family cytokines and receptors in IgG4-related disease 141
Fingerprinting of anti-citrullinated protein antibodies (ACPA): Specificity, isotypes and subclasses 140
Eotaxin-2/CCL24 and eotaxin-3/CCL26 exert differential profibrogenic effects on human lung fibroblasts 139
Mycophenolic acid suppresses human pterygium and normal tenon fibroblast proliferation in vitro 139
Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease? 136
The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta 134
IL-1 family cytokines and soluble receptors in systemic lupus erythematosus 133
Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis. 132
The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts 132
Osteopontin is expressed and functional in human eosinophils 131
Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance 131
One year in review 2019: pathogenesis of rheumatoid arthritis 129
COVID-19: the new challenge for rheumatologists 128
Mast cells and eosinophils: the hallmark of asthma. 126
Airway eosinophil accumulation and eotaxin-2/CCL24 expression following allergen challenge in BALB/c mice 125
Anti Citrullinated Peptide Antibodies profiling in established rheumatoid arthritis 124
Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab 123
New insights on the involvement of Nerve Growth Factor in allergic inflammation and fibrosis 122
Eosinophilic granulomatosis with polyangiitis with heterozygous familial hypercholesterolemia: A tricky therapeutic approach with omalizumab and evolocumab 121
HLA Shared Epitope and ACPA: just a marker or an active player? 120
Reduced eosinophil pro-fibrogenic effect in severe childhood asthma compared to mild disease: an effect of corticosteroids? 120
Targeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels 119
Immune effector cells: mast cells and eosinophils? 118
Shotgun proteomics, in-silico evaluation and immunoblotting assays for allergenicity assessment of lesser mealworm, black soldier fly and their protein hydrolysates. 115
Endostatin and Thrombospondin-1 levels are increased in the sera of patients with chronic spontaneous urticaria 114
Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling 114
COVID-19: the new challenge for rheumatologists. First update 114
Cytokines and soluble receptors of the interleukin-1 family in Schnitzler syndrome 114
The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma 113
Human peripheral blood eosinophils induce angiogenesis 113
IL-1 FAMILY CYTOKINES AND RECEPTORS IN IgG4-RELATED DISEASE 112
Fibrosis in ocular allergic inflammation: recent concepts in the pathogenesis of ocular allergy 111
CXCL12/SDF-1 in IgG4-Related Disease 111
Allergy Workup in the Diagnosis of COVID-19 Vaccines-Induced Hypersensitivity Reactions and Its Impact on Vaccination 110
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis 110
Parotid mass as an early sign of Kaposi's sarcoma associated with human herpesvirus 8 infection 109
New biomarkers in SLE: from bench to bedside 108
Nerve growth factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing 107
Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review. 106
Chronic Nerve Growth Factor Exposure Increases Apoptosis in a Model of In Vitro Induced Conjunctival Myofibroblasts 105
One year in review 2017: pathogenesis of rheumatoid arthritis 105
Mast cells in allergy and beyond 104
The role of skin tests in the prevention and diagnosis of hypersensitivity reactions to platinum agents in gynecological cancer: A single-center italian retrospective study 104
Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression? 103
Efficacy and safety of omalizumab therapy in urticaria vasculitis 102
Hypersensitivity reactions during treatment with biological agents 102
CLINICAL SIGNIFICANCE OF MULTIPLE AUTOANTIBODY SPECIFICITIES IN RHEUMATOID ARTHRITIS: THE ROLE OF ANTI-CITRULLINATED ALPHA ENOLASE AND ANTI-INTERFERON INDUCIBLE PROTEIN 16 102
Fingerprinting of anti-alpha enolase antibodies in systemic sclerosis 102
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma 102
null 101
The role of eosinophil major basic protein in angiogenesis 99
Aspirin hypersensitivity: a practical guide for cardiologists 97
Ectopic Lymphoid Organs and Immune-Mediated Diseases: Molecular Basis for Pharmacological Approaches 95
Upper and lower airway inflammation in severe asthmatics: a guide for a precision biologic treatment 93
One year in review 2021: pathogenesis of rheumatoid arthritis 92
THE ENDOGENOUS ANGIOSTATIC MEDIATORS ENDOSTATIN AND THROMBOSPONDIN-I ARE INCREASED IN SPONDYLOARTHRITIS 91
One year in review 2020: pathogenesis of rheumatoid arthritis 91
Mast cells induce activation of human lung fibroblasts in vitro 90
Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. 90
Mast cell signaling and its role in urticaria 90
Therapeutic approaches in allergic diseases 89
Patients with coronavirus disease 2019 characterized by dysregulated levels of membrane and soluble cluster of differentiation 48 84
null 84
One year in review 2018: pathogenesis of rheumatoid arthritis. 84
Severe Eosinophilic Asthma or Eosinophilic Granulomatosis With Polyangiitis: Potential Biomarkers for Novel Diagnostic Strategies 83
null 83
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis-Current Treatment and Monitoring 83
The multifaceted role of mast cells in the pathogenesis of rheumatoid arthritis 80
Angiogenesis in asthma 78
Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. 73
Nerve growth factor and eosinophils in inflamed juvenile conjunctival nevus 72
Pathogenesis of rheumatoid arthritis: one year in review 2024 71
Effects of dexamethasone on TNF-alpha-induced release of cytokines from purified human blood eosinophils 71
Salivary extracellular vesicles versus whole saliva: new perspectives for the identification of proteomic biomarkers in Sjögren’s syndrome 70
Idiopathic inflammatory myopathies and COVID-19: an intriguing liaison? 69
Component-Resolved Diagnosis for Endotyping Patients with Chronic Rhinosinusitis with Nasal Polyps 68
Symptom versus exacerbation control: an evolution in GINA guidelines? 67
Novel Methods for the Analysis of Serum NET Remnants: Evaluation in Patients with Severe COVID-19 67
Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: a pilot study 66
Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers 65
Totale 19.833
Categoria #
all - tutte 45.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.332


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021396 0 0 0 0 0 49 23 61 54 63 36 110
2021/20221.035 36 50 28 52 196 135 23 60 65 35 87 268
2022/20231.175 143 157 79 104 129 188 25 62 202 6 68 12
2023/20243.311 78 78 99 150 138 181 40 41 20 2.330 31 125
2024/20253.238 62 116 80 185 351 465 229 127 319 363 312 629
2025/20267.918 262 1.849 4.674 448 402 283 0 0 0 0 0 0
Totale 20.446